COMMUNIQUÉS West-GlobeNewswire

RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
10/06/2019
The new patent expands the robust patent portfolio covering RHB-104 and RHB-204 RedHill plans to initiate a pivotal Phase 3 study with RHB-204 for the treatment of pulmonary nontuberculous mycobacteria (NTM) infections [...]
Oncternal Therapeutics Completes Reverse Merger with GTx, Inc.
10/06/2019
Shares of Oncternal to commence trading on Nasdaq under new ticker symbol ONCT on June 10, 2019 SAN DIEGO, June 10, 2019 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc., (Nasdaq: ONCT) a clinical-stage biotechnology [...]
IntelGenx Announces Addition of Ottawa Montelukast VersaFilm® Phase 2a Clinical Trial Site; First Patient in Study Completes 26-Week Treatment
10/06/2019
SAINT LAURENT, Quebec, June 10, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), leader in pharmaceutical films, today announced that it has added a new Ottawa site in the Montelukast [...]
Entasis Therapeutics Announces Oral and Poster Presentations of its Pathogen-Targeted Antibiotic Clinical Programs at ASM Microbe 2019
10/06/2019
WALTHAM, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association
10/06/2019
NEWTOWN, Pa., June 10, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial [...]
Artizan Biosciences Announces Corporate Progress and Financing
10/06/2019
Finalized Series A funding, bringing total raised to date to $12MM to support proprietary platform that enables identification of disease-driving bacteria and development of therapies for inflammatory diseases Appointed [...]
T2 Biosystems Reports Granting of Inducement Awards
10/06/2019
LEXINGTON, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Merit Medical to Present at Raymond James Conference
10/06/2019
SOUTH JORDAN, Utah, June 10, 2019 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
BioSig Technologies Set to Join Russell 3000® Index
10/06/2019
Santa Monica, CA, June 10, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
ReWalk Robotics Announces Pricing of Registered Direct Offering for $5 Million
10/06/2019
YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into definitive agreements with [...]
Golden Leaf Holdings Launches Golden ‘Blast’ Fruit Chew, 50mg Single Serving Edible, New to Oregon Market
10/06/2019
PORTLAND, Ore., June 10, 2019 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Sienna Biopharmaceuticals Announces Late-Breaking Oral Presentation of Phase 2b Trial Results of its Topical, Non-Steroidal TrkA Inhibitor SNA-120 (0.05%) at 24th World Congress of Dermatology
10/06/2019
-- Phase 2b Trial Results Demonstrated SNA-120 Had Significant Impact on Psoriasis and Was Well-Tolerated WESTLAKE VILLAGE, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a [...]
OrthoPediatrics Corp. to Present at the JMP Life Sciences Conference
10/06/2019
WARSAW, Ind., June 10, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on advancing the field of pediatric orthopedics, announced today that [...]
electroCore Announces Frank R. Amato to Step Down as Chief Executive Officer
10/06/2019
BASKING RIDGE, N.J., June 10, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Frank R. Amato will be stepping down as Chief Executive [...]
iSage Rx Presents Positive Clinical Outcomes from Initial Study
10/06/2019
Encouraging data presented at the ADA’s 79th Scientific Sessions SAN FRANCISCO, June 10, 2019 (GLOBE NEWSWIRE) -- iSage Rx, a subsidiary of Amalgam Rx, Inc., a leading digital therapeutics company, shared findings from [...]
Ventura Cannabis to Acquire Cannabis Dispensary in Oakland, California
10/06/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ALL FIGURES IN CANADIAN DOLLARS UNLESS OTHERWISE SPECIFIED. LOS ANGELES, June 10, 2019 (GLOBE NEWSWIRE) -- Ventura [...]
Wildflower Demand Outpacing Production
10/06/2019
VANCOUVER, British Columbia, June 10, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Wildflower Brands Inc. (CSE: SUN, OTC: WLDFF) (the “ Company ” or “ Wildflower ”) announces that new production facilities are in the [...]
Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Gene Therapy for Wet AMD
10/06/2019
-- Continued Progress in the OPTIC Phase 1 Clinical Trial -- Patients Receiving Single Intravitreal Injection of ADVM-022 Dosed at 2 x 10^11 vg/eye MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Adverum [...]
CohBar poster available on preclinical results showing efficacy of a new family of mitochondria based therapeutics in a type 2 diabetes model as presented at the American Diabetes Association 79th Scientific Sessions
10/06/2019
In vitro data demonstrate interaction with the apelin receptor MENLO PARK, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company focused on developing mitochondria [...]

Pages